Sp746
LOCAL GASTROINTESTINAL REACTIONS TO FOOD IN DGBI
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI). This session will enable attendees to appreciate the interaction between different pathophysiological factors in symptom generation in DGBI, and use this knowledge to explain the underlying mechanisms to their DGBI patients.
A session focusing on recent advances in our understanding of the complex pathophysiology of disorders of gut-brain interaction (DGBI). This session will enable attendees to appreciate the interaction between different pathophysiological factors in symptom generation in DGBI, and use this knowledge to explain the underlying mechanisms to their DGBI patients.
Presenter
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
MANOMETRIC DIAGNOSIS AND TREATMENT OF RETROGRADE CRICOPHARYNGEAL DYSFUNCTION (R-CPD).
Dysphagia and chest pain are the common symptoms in achalasia. The mechanisms underlying such symptoms are not completely understood. The two symptoms can be triggered by mechanical stimulation via the sensory vagal and spinal afferent nerve fibers…
FAILURES AND SUCCESSES AMONG BIOIMARKERS FOR FUNCTIONAL DYSPEPSIA
DDW attendees will have the opportunity to learn about recent developments in biomarker-discovery for FGID/DGBI and Neurogastroenterology…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
